DFTX — Definium Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Nebius Group, Lumentum Holdings
Definium says LSD-based pill reduces anxiety in late-stage study (updated)
Definium Therapeutics rises after anxiety disorder drug meets late-stage trial goal
NASDAQ RESUMED AT 07:35 AM
Brief: Definium Therapeutics Phase 3 Voyage Study Of DT120 ODT Met Primary & Key Secondary Efficacy Endpoints
Definium says LSD-based pill reduces anxiety in late-stage study
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Definium Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Definium Therapeutics Q2 net loss widens on higher warrant costs
Brief: Definium Therapeutics Inc Q2 Net Income USD -158.986 Million
Definium Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
LSD therapy biotech Definium fends off trade-secret lawsuit (updated)
LSD therapy biotech Definium fends off trade-secret lawsuit
U.S. STOCKS ON THE MOVE-Broadcom, Micron, Qualcomm
U.S. STOCKS ON THE MOVE-Broadcom, Chemours, Qualcomm
Definium Therapeutics soars again after upsized $700 mln equity raise
Brief: Definium Prices Offering Of 20.59 Million Shares At $34/Share